DexCom (DXCM)
(Delayed Data from NSDQ)
$76.55 USD
+0.97 (1.28%)
Updated Sep 16, 2025 04:00 PM ET
After-Market: $76.67 +0.12 (0.16%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth C Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
DXCM 76.55 +0.97(1.28%)
Will DXCM be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for DXCM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for DXCM
Investing in the Age of Longevity: Silver Economy Stocks in Focus
Why Is DexCom (DXCM) Down 7% Since Last Earnings Report?
DXCM: What are Zacks experts saying now?
Zacks Private Portfolio Services
DexCom Expands Access and Innovation While Balancing Headwinds
Trinity Biotech's Redesigned CGM Sensor Favored by New Clinical Data
Abbott's Q2 Diabetes Care Sales Rise 19.6%: What's Backing It?
Other News for DXCM
DexCom, Inc. (DXCM) Announces Temporary Leadership Changes Amid CEO's Medical Leave
DXCM forms 20 Day Moving Average Resistance on September 15
DexCom (DXCM) Appoints Interim CEO Amid Executive Medical Leave
DexCom CEO takes medical leave
Dexcom CEO Takes Medical Leave, Interim Roles Announced